National Institutes of Health, a Component of the US Dept. of Health & Human Services

Provid Pharmaceuticals Inc.

Eleison Pharmaceuticals, LLC

Guangtao Zhang

Yves Pommier

Christopher Self

Robert H Shoemaker

Michael Currens

John Cardellina

Dominic Scudiero

David Waugh

George Lountos

Charles Michael Cook

Forrest H Anthony

Andrew Vargha Colasanti

Andrew Jobson

Matthew M Parris

Andy Jobson

Sudhir Kondapaka

Edwin J Thomas

Christopher R Self

Charles M Cook

Robert Shoemaker

Andrew Colasanti

The described invention provides methods for treating pulmonary cancer in a subject, by administering to the subject by inhalation a composition of inhalational lipid cisplatin (ILC) comprising a lipid-complexed cisplatin.

Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin

A method of treating an Hepatitis C Virus infection in a patient, comprising providing a therapeutically effective amount, to a patient in need thereof, of a compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein: Gis a group of the formula or where n is 0, 1, 2, 3, or 4 and Het is a 5- or 6-membered heteroaryl group containing 1 to 4 heteroatoms independently chosen from N, O, and S, which Het is optionally substituted. 

Method of treating HCV infection with a small molecule CHK2 inhibitor

Provided herein are Compounds having the following structure: 

Kinase inhibitors, compositions thereof, and methods of use therewith

Growing community of inventors

Princeton, NJ, United States of America

Guangtao Zhang